Futura Medical is an innovative R&D company with a pipeline of products in late stage development. We are experts in transdermal delivery and have developed an advanced proprietary transdermal technology, DermaSys®. Our lead product MED2005, is a breakthrough topical treatment for erectile dysfunction currently in Phase 3 clinical trials with potential peak sales of $1bn. Our strategy is to develop our innovative product portfolio to late stage and then to partner with major pharmaceutical partners. We are based in Guildford, UK and are listed on the AIM market of the London Stock Exchange.
Our products are unique thanks to our proprietary, transdermal Dermasys® drug delivery technology platform, which is designed to drive more active compound through the skin for an effective and targeted delivery.